Compare Imcivree vs. Wegovy
Head-to-head comparisons of medication uses, side effects, warnings, and more.
Summary of Imcivree vs. Wegovy
Imcivree (setmelanotide) is an injectable medication that's used for weight management in people over the age of 6 with certain rare genetic conditions. It's the first FDA-approved treatment that specifically helps with obesity in people with Bardet-Biedl syndrome (BBS) and people with POMC, PCSK1, or LEPR deficiency. Imcivree (setmelanotide) is a melanocortin agonist that works in the brain to lessen appetite and make the body use up more energy. This medication is injected under the skin once a day. Side effects include injection site reactions, nausea, and more seriously, depression and suicidal thoughts.
Wegovy (semaglutide) is used in addition to a lower-calorie diet and exercise plan to help with weight loss in certain adults and children 12 years of age and older. It's also proven to lower the risk for heart attack, stroke, and death due to heart problems in adults with a larger body size and heart disease. This medication belongs to the drug class called glucagon-like peptide-1 (GLP-1) receptor agonists. The dosing schedule for Wegovy (semaglutide) is once a week, and the medication is injected under your skin. Common side effects include nausea, diarrhea, and stomach pain.
Indications of Imcivree vs. Wegovy
Pros and Cons of Imcivree vs. Wegovy
Common Side Effects of Imcivree vs. Wegovy
Warnings of Imcivree vs. Wegovy
Prices with our coupons for Imcivree vs. Wegovy
Compare other Weight Loss drugs
Browse medications
View AllResearch prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.